Semaglutide
Semaglutide in Treatment of Obesity
Novo Nordisk · Phase 3 · Completed · Enrollment 462
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HD1916 | Obesity or overweight | n/r | n/r | n/r | n/r |
| semaglutide | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Semaglutide
Novo Nordisk · Phase 3 · Completed · Enrollment 462
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HD1916 | Obesity or overweight | n/r | n/r | n/r | n/r |
| semaglutide | Obesity or overweight | n/r | n/r | n/r | n/r |